Back to results
US 2021/0329895 A1Published application
Non-human animals having a humanized b-cell activating factor gene
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsJohn McWhirter, Cagan Gurer, Lynn Macdonald, Andrew J. Murphy
Life of this patent
Estimating the term…
Abstract
Non-human animals, cells, methods and compositions for making and using the same are provided, wherein the non-human animals and cells comprise a humanized B-cell activating factor gene. Non-human animals and cells that express a human or humanized B-cell activating factor protein from an endogenous B-cell activating factor locus are described.
Claims10
-21. (canceled)
An isolated mouse cell or tissue whose genome comprises
- a replacement of a mouse genomic fragment comprising exons 3-6 of an endogenous mouse B-cell Activating Factor (Baff) gene at an endogenous mouse Baff locus in the mouse ES cell, with a human genomic fragment comprising exons 3-6 of a human BAFF gene to form a humanized Baff gene,
- wherein the coding exons of the humanized Baff gene consist of exons 1-2 of the endogenous mouse Baff gene and exons 3-6 of the human BAFF gene,
- wherein the humanized Baff gene is under control of the mouse Baff promoter at the endogenous mouse Baff locus and encodes a humanized Baff protein comprising an extracellular portion of the human BAFF protein linked to an intracellular portion of the mouse Baff protein encoded by the endogenous mouse Baff gene,
- wherein the extracellular portion of the human BAFF protein is at least 98% identical to the amino acid sequence as set forth in amino acids 142 to 285 of SEQ ID NO:
- 5, and
- wherein the mouse cell or tissue expresses thed humanized Baff protein.
3 more elements
A cell or tissue isolated from a mouse, wherein the mouse genome comprises
- a replacement of a mouse genomic fragment comprising exons 3-6 of an endogenous mouse B-cell Activating Factor (Baff) gene at an endogenous mouse Baff locus in the mouse ES cell, with a human genomic fragment comprising exons 3-6 of a human BAFF gene to form a humanized Baff gene,
- wherein the coding exons of the humanized Baff gene consist of exons 1-2 of the endogenous mouse Baff gene and exons 3-6 of the human BAFF gene,
- wherein the humanized Baff gene is under control of the mouse Baff promoter at the endogenous mouse Baff locus and encodes a humanized Baff protein comprising an extracellular portion of the human BAFF protein linked to an intracellular portion of the mouse Baff protein encoded by the endogenous mouse Baff gene,
- wherein the extracellular portion of the human BAFF protein is at least 98% identical to the amino acid sequence as set forth in amino acids 142 to 285 of SEQ ID NO:
- 5,
- wherein the mouse expresses the humanized Baff protein, and
- wherein the cell or tissue comprises the humanized Baff gene.
4 more elements
A targeting vector, comprising
- a human genomic fragment comprising exons 3-6 of a human BAFF gene, flanked by a 5′ nucleic acid sequence and a 3′ nucleic acid sequence,
- wherein the 5′ nucleic acid sequence comprises (i) about 14.5 kb mouse genomic sequence upstream of exon 1 of a mouse Baff gene, and (ii) exon 1 and exon 2 of the mouse Baff gene,
- wherein the 3′ nucleic acid sequence comprises a mouse genomic sequence 3′ to the mouse Baff gene,
- wherein the 5′ and 3′ nucleic acid sequences mediate integration of the human genomic fragment into a mouse Baff locus which results in a replacement of a genomic fragment of the mouse Baff gene to form a humanized Baff gene,
- wherein the coding exons of the humanized Baff gene consist of exons 1-2 of the mouse Baff gene and exons 3-6 of the human BAFF gene,
- wherein the humanized Baff gene is under control of the mouse Baff promoter at the mouse Baff locus and encodes a humanized Baff protein comprising an extracellular portion of the human BAFF protein linked to an intracellular portion of the mouse Baff protein encoded by the mouse Baff gene, and
- wherein the extracellular portion of the human BAFF protein is at least 98% identical to the amino acid sequence as set forth in amino acids 142 to 285 of SEQ ID NO:
- 5.
5 more elements
Dependencies are inferred from the claim text.